Searchable abstracts of presentations at key conferences in endocrinology

ea0011p234 | Cytokines and growth factors | ECE2006

Possible predictive value of IGF-II mRNA expression in breast cancer (BC)

Giani CG , Giustarini EG , Fierabracci PF , Campani DC , Lippman MEL

Insuline like growth factor II (IGF II) is an important regulator of neoplastic growth and it is stromal in origin. Estrogen and Progesterone receptor (ER, PR) are considered a good prognostic predictors in BC. The aim of the study was to evaluate the impact of IGF II mRNA expression in the clinical outcome in breast malignancy. The study group included 75 women (mean age ±S.D.=53.3±15.6 yr) submitted to radical mastectomy for ductal infiltrating breas...

ea0011p485 | Endocrine tumours and neoplasia | ECE2006

Thyroid autoimmunity disorders and breast cancer (BC): absence of morphological autoimmune changes in breast malignant tissue

Giustarini EG , Pinchera AP , Fierabracci PF , Campani DC , Giani CG

Thyroid autoimmunity and BC are strongly related, but the cause of this association is unknown. In BC an increase of lymphoid cell infiltrates may be detected very early during tumor development. BC cells share some antigenic properties similar to those detected in thyroid tissue, as NIS and peroxidase activity and it is possible that in patients with BC and thyroid autoimmunity, should be present serum immunoglobulins reacting with these specific antigenes.<p class="abste...

ea0011p235 | Cytokines and growth factors | ECE2006

IGF II protein expression in breast cancer. Relationship with the most important predictive parameters in breast malignancy

Giustarini EG , Pinchera AP , Campani DC , Fierabracci PF , Cullen KC , Giani CG

Recent in situ hybridization data showed high content of IGF-II mRNA in the stroma of breast cancer. The aim of this study was to examine the expression of IGF-II protein and its relationship with several prognostic parameters in 75 ductal infiltrating carcinoma (DIC) of the breast.The tissue sections were evaluated for IGF II protein, proliferating activity, ER, PR, p53, P21 oncogene expression using immunohistochemical procedures. The amoumt of ...